Psychedelic Drugs Reveal Distinct Neural Patterns in the Brain
Researchers have discovered a unique signature created by psychedelic substances in the brain, observable during their mind-altering effects.
This “neural fingerprint” was identified in a large collection of brain scans from individuals using LSD, psilocybin, DMT, mescaline, and ayahuasca, illustrating a common influence on brain activity.
The results stem from a comprehensive study that integrated 11 brain imaging datasets from various parts of the globe, aiming to illustrate how these substances temporarily alter brain wiring.
These findings could be particularly relevant as scientists explore the potential of these drugs as therapies for serious mental health and neurological issues such as depression, schizophrenia, and post-traumatic stress disorder.
“These five substances, which have never been analyzed together in terms of their effects on the brain, share certain commonalities in how they alter brain function,” explained Dr. Danilo Bzdok, a senior author involved in the research from McGill University in Montreal, Canada.
He elaborated, “All five substances seem to disrupt the usual order, effectively flattening the hierarchy of brain systems, which may explain what some people refer to as a raw access to one’s own consciousness.”
Scientists have long been interested in uncovering how psychedelics induce hallucinations and contribute to the feeling of self-dissolution, where individuals experience a breakdown of their identity. However, many prior studies have been limited in scale, complicating definitive conclusions.
In their publication in Nature Medicine, Bzdok and his team analyzed over 500 brain scans from 267 participants across five countries, claiming it’s the largest exploration of psychedelics and brain function to date.
While variations existed in how each substance influenced brain activity, a significant similarity was observed in their effects on communication among brain regions. A particularly notable finding was enhanced interaction between higher-order thinking networks and more basic networks associated with sensations and vision.
“There’s a release of cross-talk among brain systems – they are communicating in a chaotic manner,” Bzdok noted. “Excessive cross-talk is noticeable between the systems.”
Moreover, the research revealed additional changes in deeper brain areas connected to habits, learning, and movement. Contrary to some earlier beliefs, there was minimal evidence found to support claims that certain brain networks “disintegrate” while on psychedelics.
Bzdok suggested that these findings could stabilize psychedelic research, which is essential if these substances are to be adopted as mainstream treatments for mental health issues.
“This field is developing rapidly but is currently on unstable ground; it’s like building houses on matches,” Bzdok said. “We initiated the study with the goal of laying a strong foundation.”
Dr. Emmanuel Stamatakis, a senior co-author from the University of Cambridge, emphasized the importance of large-scale, coordinated studies in the fast-evolving field of psychedelic research. “If we want this area to mature properly, we need substantial, consolidated evidence,” he remarked.
